Ibrutinib-Associated Reversible Cardiomyopathy

J Oncol Pract. 2019 Dec;15(12):671-673. doi: 10.1200/JOP.19.00334. Epub 2019 Oct 16.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Aged
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / diagnosis*
  • Cardiomyopathies / physiopathology
  • Humans
  • Lymphoma, Mantle-Cell / complications
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / pathology
  • Male
  • Mesentery / drug effects
  • Mesentery / pathology
  • Piperidines
  • Pyrazoles / administration & dosage
  • Pyrazoles / adverse effects*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine